Title
Category
Credits
Event date
Cost
Skilled Nursing Facilities Series: Preventing Unsafe and Avoidable Hospitalizations
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This activity will identify conditions that require hospitalization and the potential risks and complications that hospitalizations can pose. The importance of timely identification of resident problems and accurate communication with health care providers who deliver care for residents will also be discussed.
Heart Failure: Diagnosis and Initial Management for the Primary Care Provider
  • Cardiology
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This on-demand webcast is designed to enhance primary care providers’ understanding of the evolving landscape of heart failure classification and treatment. Participants will explore the current nomenclature for heart failure staging and functional classification, with a focus on stratification by ejection fraction. The session will review the latest guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), including updates on pharmacologic and device-based interventions. Additionally, common barriers to implementing optimal therapy will be discussed, along with practical strategies to improve adherence and patient outcomes.
Managing Urinary Incontinence
  • Disease management
  • Older adults
  • Wellness
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
$0.00
This activity will highlight the prevalence of UI; provide effective communication and shared decision-making techniques; and discuss how to assess, treat and provide follow-up care for UI including available resources to support care and management.
Unlocking Patient-reported Outcomes to Advance Quality, Experience and Decision Making
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This activity will explore the value of PRO measures in the health system and discuss methods of optimally integrating these measures. It will discuss strategies that the health care team and health system can use to interpret and apply PRO data to add value to current care delivery practices.
Skilled Nursing Facilities Series: How to De-escalate Behaviors
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This on-demand webcast will discuss behaviors secondary to dementia and the appropriate pharmacological and non- pharmacological interventions with careful consideration of the risks and benefits of medication treatment.
Advancing Care in GVHD: Strategies for Improved Outcomes
  • Disease management
  • Transplantation
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Essentials of Oncology and Transplant Management is designed for all who are interested in learning best practices for optimal patient and/or benefit management in the fields of transplant medicine and oncology.
Heart-Allocation Policy and Implications for VADs and Transplant Outcomes
  • Disease management
  • Transplantation
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Essentials of Oncology and Transplant Management is designed for all who are interested in learning best practices for optimal patient and/or benefit management in the fields of transplant medicine and oncology.
AI-Powered Transplant Success: Optimizing Organ Allocation
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore the ways in which artificial intelligence (AI) can improve organ allocation and transplantation medicine. This session will delve into how AI-driven algorithms enhance organ-matching precision, help predict transplant outcomes and optimize postoperative care. Participants will gain insight into the practical integration of AI into transplant practices, learn innovative strategies, and discuss real-world examples that demonstrate improved patient care and improve transplant success rates.
From Diagnosis to Recovery: The Human and Medical Aspects of Organ Transplant
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
ACTIVITY DESCRIPTIONThis activity consists of a recorded presentation from the "34th Annual National Conference" held in Minneapolis, Minn., May 13-15, 2025.
Advancements in Pediatric Oncology: Genetic Testing and Targeted Therapies
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This session will provide participants with an in-depth understanding of the role of genetic testing in pediatric oncology, focusing on the use of germline and tumor genetic testing in diagnosing and treating pediatric cancers. It will explore the development and application of rare-disease specific drugs as models for targeted therapy and analyze the differences and similarities in cancer development between pediatric and adult patients, highlighting the implications for treatment strategies. Participants will also develop strategies for incorporating genetic testing and targeted therapies into routine clinical practice.

Pages